Skip to content

Vivamed

2 viewers · 30d

Total raised

$3.0M

+$3.0M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.0M
ROUNDS
1
INVESTORS
1
FOUNDED
2024
HQ
Santa Monica, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Vivamed is a Santa Monica, California medical device company developing a minimally invasive implant that treats obstructive sleep apnea (OSA) with hypoglossal nerve stimulation. Its device is described as wireless and battery-less, removing the large surgical incisions and implanted power source that current hypoglossal nerve stimulation systems require. The company was founded in 2024 out of UCLA by CEO Sepideh Nouri and is a member of the Medical Technology Enterprise Consortium (MTEC) and a Creative Destruction Lab 2024/25 cohort company. It is pre-commercial and raising seed capital.

What sets it apart

Wireless, battery-less hypoglossal nerve stimulation, which removes the implanted pulse generator and battery that force large incisions in existing systems - shortening surgery and recovery, widening physician adoption, and lowering the cost of the therapy to the health system.

Funding history

1 round
Equity+2May 18, 2026
Form D
+$3.0M$3.0M total

Latest SEC filings

via EDGAR · CIK 0002066306
Form D · May 18, 2026NewView on EDGAR

Products

1 tracked

Minimally invasive hypoglossal nerve stimulation implant

Implantable medical device

An implantable neuromodulation device that stimulates the hypoglossal nerve to keep the upper airway open during sleep, positioned by the company as 'Transforming Obstructive Sleep Apnea Treatment with Minimally Invasive Neuromodulation.'

  • Hypoglossal nerve stimulation for obstructive sleep apnea
  • Wireless operation
  • Battery-less - no implanted power source
  • Minimally invasive implantation, avoiding large surgical incisions

Links

WebsiteLinkedInSEC EDGAR filings